{"url_path":"/sec/tnon/8-k/2026-07-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-02","source_url":"https://www.sec.gov/Archives/edgar/data/1560293/0001213900-26-074953-index.html","accession_number":"0001213900-26-074953","cik":"0001560293","ticker":"TNON","issuer_name":"Tenon Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1560293/0001213900-26-074953-index.html","primary_entity_key":"0001560293","primary_entity_name":"Tenon Medical, Inc."},"word_count":143,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\nThe following exhibits are being filed herewith:\n\n \n\n**Exhibit No.**\n \n**Description**\n\n1.1\n \n[Placement Agency Agreement, dated as of June 29, 2026, by and between Tenon Medical, Inc. and WallachBeth Capital, LLC](ea029678001ex1-1.htm)\n\n4.1\n \n[Form of Common Warrant](ea029678001ex4-1.htm)\n\n4.2\n \n[Form of Pre-Funded Warrant](ea029678001ex4-2.htm)\n\n4.3\n \n[Form of Placement Agent Warrant](ea029678001ex4-3.htm)\n\n10.1\n \n[Form of Securities Purchase Agreement](ea029678001ex10-1.htm)\n\n99.1\n \n[Pricing Press Release dated June 30, 2026](ea029678001ex99-1.htm)\n\n99.2\n \n[Closing Press Release dated July 1, 2026](ea029678001ex99-2.htm)\n\n104\n \nCover Page Interactive Data File (embedded with the Inline XBRL document).\n\n \n\n3\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities\nExchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: July 2, 2026\n**TENON MEDICAL, INC.**\n\n \n \n \n\n \nBy:\n*/s/ Steven M. Foster*\n\n \nName:\nSteven M. Foster\n\n \nTitle:\nChief Executive Officer and President\n\n \n\n \n\n4"}